CLVLF
CLINUVEL PHARMS ORD by Clinuvel Pharmaceuticals Ltd. (CLVLF)
$45
About CLINUVEL PHARMS ORD by Clinuvel Pharmaceuticals Ltd. (CLVLF)
Clinuvel Pharmaceuticals Ltd. operates as a biopharmaceutical company. The firm engages in the development of SCENESSE, its proprietary photoprotective drug. It also offers drugs for the treatment of various skin disorders. The company was founded by Robert Thomas Dorr on December 14, 1999 and is headquartered in Melbourne, Australia.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$11.55
52 Week Low
$6.90
Market cap
373.2M
Dividend yield
0.45%
Volume
25
Avg. volume
5
P/E ratio
14.58
CLINUVEL PHARMS ORD by Clinuvel Pharmaceuticals Ltd. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$11.55
52 Week Low
$6.90
Market cap
373.2M
Dividend yield
0.45%
Volume
25
Avg. volume
5
P/E ratio
14.58